- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Sofosbuvir with velpatasvir – July 2017
Sofosbuvir with velpatasvir: Tablet containing 400 mg sofosbuvir with 100 mg velpatasvir; Epclusa®
Last updated
10 November 2017